Lorena López-González

552 total citations
32 papers, 391 citations indexed

About

Lorena López-González is a scholar working on Economics and Econometrics, Immunology and Oncology. According to data from OpenAlex, Lorena López-González has authored 32 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Economics and Econometrics, 7 papers in Immunology and 6 papers in Oncology. Recurrent topics in Lorena López-González's work include Lung Cancer Research Studies (5 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Lorena López-González is often cited by papers focused on Lung Cancer Research Studies (5 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Lorena López-González collaborates with scholars based in United States, Spain and Canada. Lorena López-González's co-authors include Robert A. Hummer, Robert Crosnoe, Emily Durden, Richard Barron, Paul Juneau, Lionel Pinto, Chandra Muller, Raynard Washington, Gary Pickens and J Langer and has published in prestigious journals such as Blood, Social Forces and Clinical Therapeutics.

In The Last Decade

Lorena López-González

31 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorena López-González United States 10 99 82 78 72 67 32 391
Michelle L. Johnson United States 11 24 0.2× 26 0.3× 63 0.8× 135 1.9× 26 0.4× 19 553
Abdallah Al‐Ani Jordan 10 34 0.3× 53 0.6× 42 0.5× 48 0.7× 24 0.4× 68 365
Patricia Greenberg United States 11 31 0.3× 78 1.0× 72 0.9× 45 0.6× 15 0.2× 66 453
Tasnima Abedin Canada 9 40 0.4× 24 0.3× 79 1.0× 101 1.4× 16 0.2× 25 333
Karen Collins United States 9 31 0.3× 35 0.4× 194 2.5× 66 0.9× 65 1.0× 19 495
Veronica Nanton United Kingdom 12 61 0.6× 60 0.7× 149 1.9× 188 2.6× 6 0.1× 31 496
Vera Vennedey Germany 14 30 0.3× 24 0.3× 35 0.4× 246 3.4× 19 0.3× 27 531
Justin M. Dubin United States 13 29 0.3× 37 0.5× 121 1.6× 162 2.3× 7 0.1× 53 551
Alexandra Hernández United States 11 85 0.9× 29 0.4× 182 2.3× 82 1.1× 4 0.1× 50 598
Elizabeth Mollard United States 14 43 0.4× 101 1.2× 14 0.2× 117 1.6× 7 0.1× 31 403

Countries citing papers authored by Lorena López-González

Since Specialization
Citations

This map shows the geographic impact of Lorena López-González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorena López-González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorena López-González more than expected).

Fields of papers citing papers by Lorena López-González

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorena López-González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorena López-González. The network helps show where Lorena López-González may publish in the future.

Co-authorship network of co-authors of Lorena López-González

This figure shows the co-authorship network connecting the top 25 collaborators of Lorena López-González. A scholar is included among the top collaborators of Lorena López-González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorena López-González. Lorena López-González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olson, C., Thomas L. Ray, Lorena López-González, et al.. (2024). LONG-TERM PROPHYLACTIC TREATMENT PREFERENCES OF PATIENTS WITH HEREDITARY ANGIOEDEMA. Annals of Allergy Asthma & Immunology. 133(6). S28–S28. 1 indexed citations
2.
Goldschmidt, Jerome H., Lowell L. Hart, Jeffrey A. Scott, et al.. (2023). Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy. Advances in Therapy. 40(10). 4189–4215. 3 indexed citations
4.
Hart, Lowell L., Augustina Ogbonnaya, Kathryn A. DeYoung, et al.. (2023). Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices. Cancer Medicine. 12(8). 10020–10030. 7 indexed citations
6.
7.
Feldman, Steven R., Jingchuan Zhang, Lorena López-González, et al.. (2021). Real-world biologic and apremilast treatment patterns in patients with psoriasis and psoriatic arthritis. Dermatology Online Journal. 27(9). 3 indexed citations
8.
Kaplowitz, Paul B., et al.. (2021). Economic Burden of Growth Hormone Deficiency in a US Pediatric Population. Journal of the Endocrine Society. 5(Supplement_1). A675–A675. 2 indexed citations
9.
Zhang, Xinke, et al.. (2018). Economic Burden of Veno-occlusive Disease in Patients With B-cell Acute Lymphoblastic Leukemia in the United States. Clinical Therapeutics. 40(10). 1711–1719.e1. 4 indexed citations
10.
Zhang, Xinke, et al.. (2018). Economic burden associated with adverse events of special interest in patients with relapsed Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in the United States. Expert Review of Pharmacoeconomics & Outcomes Research. 18(5). 573–580. 6 indexed citations
11.
Boklage, Susan, et al.. (2018). Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions. Cardiovascular Drugs and Therapy. 32(3). 273–280. 8 indexed citations
13.
Song, Xue, et al.. (2017). Economic Burden of Veno-Occlusive Disease (VOD) in Patients with Acute Lymphoblastic Leukemia (ALL) in the US. Blood. 130. 5611–5611. 1 indexed citations
14.
Durden, Emily, Lionel Pinto, Lorena López-González, Paul Juneau, & Richard Barron. (2017). Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States. Archives of Osteoporosis. 12(1). 22–22. 79 indexed citations
15.
Henke, Rachel Mosher, et al.. (2015). Racial and Ethnic Disparities in Health Among Employees at Large Firms. Journal of Occupational and Environmental Medicine. 57(6). 627–634. 2 indexed citations
16.
Durden, Emily, et al.. (2015). Predictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States. Journal of Medical Economics. 19(4). 403–413. 16 indexed citations
17.
López-González, Lorena, Gary Pickens, Raynard Washington, & Audrey J Weiss. (2014). Characteristics of Medicaid and Uninsured Hospitalizations, 2012. 26(189). 99–102. 10 indexed citations
18.
López-González, Lorena, et al.. (2006). Characteristics of Medicaid and Uninsured Hospitalizations, 2012: Statistical Brief #182. 9 indexed citations
19.
Crosnoe, Robert & Lorena López-González. (2005). Immigration from Mexico, School Composition, and Adolescent Functioning. Sociological Perspectives. 48(1). 1–24. 28 indexed citations
20.
López-González, Lorena, et al.. (2005). Immigrant Acculturation, Gender and Health Behavior: A Research Note. Social Forces. 84(1). 581–593. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026